Literatür

Last modification: 2011/08/22 https://kinderkrebsinfo.de/doi/e8952

Autor(en) Titel Quelle Links
Haaf H, Kaatsch P, Keller B, Michaelis J Regionale Analysen der Krebsinzidenz bei kleinen Fallzahlen. Gesundheit und Umwelt 1992, 273    
Haas R, Schmidt P, Göbel U, Harms D Therapy of testicular germ cell tumors. Current status of the MAHO studies. Klin Pädiatr 1993, 205: 225    
Haas R, Schmidt P, Göbel U, Harms D Treatment of malignant testicular tumors in childhood. Med Pediatr Oncol 1994, 23: 400    
Haas R, Schmidt P Testicular germ-cell tumors in childhood and adolescence. World J Urol 1995, 13: 203    
Haas R, Schmidt P, Göbel U, Harms D Testicular germ cell tumors. Results of the GPO MAHO studies -82-88-92. Klin Pädiatr 1995, 207: 145    
Haas R, Schmidt P, Göbel U, Harms D Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997. Klin Pädiatr 1999, 211: 300    
Haase R, Vilser C, Mauz-Körholz C, Hasenclever D, Kluge R, Ruschke K, Borkhardt A, Seeger K, Lehrnbecher T, Kulozik A, Rößler J, Burdach S, Jürgens H, Körholz D Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL). Klinische Padiatrie 2012t; 224: 377    
Haberle B, Hero B, Berthold F, von Schweinitz D Characteristics and outcome of thoracic neuroblastoma. Eur J Pediatr Surg 2002, 12: 145    
Haberle B, Bode U, von Schweinitz D Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99. Klin Pädiatr 2003, 215: 159    
Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes. American journal of hematology 2016, 91: 989    
Hadrich D, Berthold F, Steckhan E, Bonisch H Synthesis and characterization of fluorescent ligands for the norepinephrine transporter. J Med Chem 1999, 42: 3101    
Haecker F, von Schweinitz D, Harms D, Buerger D, Graf N Partial nephrectomy for unilateral Wilms tumor. J Urol 2003, 170: 939    
Haeusler J, Ranft A, Boelling T, Gosheger G, Braun-Munzinger G, Vieth V, Burdach S, van den Berg H, Jürgens H, Dirksen U The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer 2010, 116: 443    
Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, Lopez-Terrada D, Aronson DC, Alaggio R, Ansari M, Malogolowkin MH, Perilongo G, O'Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, von Schweinitz D, Ranganathan S, Yoshimura K, Hishiki T, Tanaka Y, Piao J, Feng Y, Rinaldi E, Saraceno D, Derosa M, Meyers RL The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database. Pediatric blood & cancer 2020, 67:e28350    
Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006, 117: 698    
Hagel C, Treszl A, Fehlert J, Harder J, von Haxthausen F, Kern M, von Bueren AO, Kordes U Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression. Journal of neuro-oncology 2013, 112: 191    
Hagel C, Sloman V, Mynarek M, Petrasch K, Obrecht D, Kühl J, Deinlein F, Schmid R, von Bueren AO, Friedrich C, Juhnke BO, Gerber NU, Kwiecien R, Girschick H, Höller A, Zapf A, von Hoff K, Rutkowski S Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial. European journal of cancer (Oxford, England : 1990) 2022, 164: 30    
Halperin EC, Friedman HS, Schold SC Jr, Fuchs HE, Oakes WJ, Hockenberger B, Burger PC Surgery, hyperfractionated craniospinal irradiation, and adjuvant chemotherapy in the management of supratentorial embryonal neuroepithelial neoplasms in children. Surgical neurology 1993, 40: 278    
Halimeh S Menorrhagia and bleeding disorders in adolescent females. Hamostaseologie 2012, 32: 45    
Halimeh S, Bidlingmaier C, Heller C, Gutsche S, Holzhauer S, Kenet G, Kurnik K, Manner D, Iorio A, Nowak-Göttl U Risk factors for high-titer inhibitor development in children with hemophilia A: results of a cohort study. BioMed research international 2013, 2013, 901975    
Hallberg B, Palmer RH Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nature reviews. Cancer 2013, 13: 685    
Hammerle K, Shayan P, Niemeyer CM, Flotho C Expression analysis of alpha-NAC and ANX2 in juvenile myelomonocytic leukemia using SMART polymerase chain reaction and. Cancer genetics and cytogenetics 2003, 142: 149    
Hammer GP, Seidenbusch MC, Schneider K, Regulla DF, Zeeb H, Spix C, Blettner M A cohort study of childhood cancer incidence after postnatal diagnostic X-ray exposure. Radiation research 2009, 171: 504    
Hamideh D, Alvarez O Sickle Cell Disease Related Mortality in the United States (1999-2009). Pediatric blood & cancer 2013, epub ahead of print    
Hammoudi N, Lionnet F, Redheuil A, Montalescot G Cardiovascular manifestations of sickle cell disease. Eur heart j 2020, 41: 1365    
Hammer ASB, Juul-Dam KL, Sandahl JD, Abrahamsson J, Czogala M, Delabesse E, Haltrich I, Jahnukainen K, Kolb EA, Kovács G, Leverger G, Locatelli F, Masetti R, Noren-Nyström U, Raimondi SC, Rasche M, Reinhardt D, Taki T, Tomizawa D, Zeller B, Hasle H, Kjeldsen E Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration. Blood advances 2023, 7: 1045    
Hansmann C, Faber J, Lauth GW, Oldenburg M, Török M Zwischenbericht zur „Untersuchung der heutigen Situation erwachsener Hämophiler“ im norddeutschen Raum. Hämophilieblätter 1987, H.1: 27    
Hanenberg H, Batish SD, Pollok KE, Vieten L, Verlander PC, Leurs C, Cooper RJ, Göttsche K, Haneline L, Clapp DW, Lobitz S, Williams DA, Auerbach AD Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol 2002, 30: 410    
Hanke CA, Roessler J, Stegmaier S, Koscielniak E, Niemeyer CM, Kontny U Alveolar rhabdomyosarcoma mimicking lymphoma with bone marrow involvement. European journal of pediatrics 2007, 166: 505    
Hanebutt FL, Rolf N, Loesel A, Kuhlisch E, Siegert G, Knoefler R Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders. Haemophilia 2008, 14: 524    
Handgretinger R, Zugmaier G, Henze G, Kreyenberg H, Lang P, von Stackelberg A Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia. Leukemia 2010 Oct 14;    
Hanahan D, Weinberg RA Hallmarks of cancer: the next generation. Cell 2011 Mar 4; 144: 646    
Handgretinger R, Zugmaier G, Henze G, Kreyenberg H, Lang P, von Stackelberg A Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia. Leukemia 2011, 25: 181    
Handgretinger R, Matthes-Martin S, Lang P Hämatopoetische Stammzelltransplantation. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie, Springer-Verlag GmbH Deutschland 2. vollständig überarbeitete Auflage 2018, 17    
Hanitsch L, Baumann U, Boztug K, Burkhard-Meier U, Fasshauer M, Habermehl P, Hauck F, Klock G, Liese J, Meyer O, Müller R, Pachlopnik-Schmid J, Pfeiffer-Kascha D, Warnatz K, Wehr C, Wittke K, Niehues T, von Bernuth H Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline. European journal of immunology 2020, 50: 1432    
Harisiadis L, Chang CH Medulloblastoma in children: a correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys 1977 (9-10): 833    
Harbott J, Budde M, Creutzig U, Engel R, Fengler R, Rudolph B, Lampert F Prognostic meaning of chromosome aberrations in acute lymphocytic leukemia and acute nonlymphocytic leukemia patients of the BFM study group. Haematology and Blood Transfusion 1987, 30: 497    
Harbott J, Ritterbach J, Creutzig U, Riehm H, Lampert F Cytogenetic findings in acute leukemias of infants. Contrib Oncol 1990, 41: 50    
Harms D, Gortitz I, Lambrecht W, Kabisch H, Erttmann R, Janka-Schaub G Infectious risks of Broviac catheters in children with neoplastic diseases. Pediatr Infect Dis J 1992, 11: 1014    
Harbott J, Ritterbach J, Ludwig W, Bartram C, Reiter A, Lampert F Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia. Recent Results Cancer Res 1993, 131: 123    
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84: 1361-92.    
Hartmann S, Schäper E, Lamprecht-Dinnesen A, Boos J Ototoxizität von Cisplatin im Kindesalter. Oto Rhino Laryng 1995, 222    
Harbott J, Reinisch-Becker I, Ritterbach J, Creutzig U, Ludwig W, Gutjahr P, Borkhardt A, Lampert F Karyotypic abnormalities in secondary leukemia of children. Haematology and Blood Transfusion 1996, 38: 24    
Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 1997, 90: 4933    
Harms D, Jänig U, Göbel U Pathology of germ cell tumors. Report of the Kiel pediatric tumor registry (KPTR). Med Pediatr Oncol 1998, 31: 189    
Harms D, Leuschner I, Krams M, Pilgrim T, Treuner J Rhabdomyosarcoma and extraosseous Ewing's sarcoma. Verh Dtsch Ges Pathol 1998, 82: 83    
Harms D, Janka-Schaub G Co-operative study group for childhood acute lymphoblastic leukemia (COALL). Leukemia 2000, 14: 2234    
Hartmann O, Berthold F Treatment of advanced Neuroblastoma:the European Experience, in Brodeur G, M.; Sawada Y; Tsuchida Y; Voute,Pd (Hrsg.), Neuroblastoma. Elsevier 2000, 437    
Hartmann W, Waha A, Koch A, Goodyer C, Albrecht S, von Schweinitz D, Pietsch T p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19. Am J Pathol 2000, 157: 1393    
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J Lymphoma classification--from controversy to consensus: the R. E.A. L. and WHO Classification of lymphoid neoplasms. Ann Oncol 2000, 11 Suppl 1: 3-10. Review.    
Harms D, Göbel U, Spaar H, Graubner U, Jorch N, Gutjahr P, Janka-Schaub G Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL. Blood 2003, 102: 2736    
Hartmann W, Küchler J, Koch A, Friedrichs N, Waha A, Endl E, Czerwitzki J, Metzger D, Steiner S, Wurst P, Leuschner I, von Schweinitz D, Buettner R, Pietsch T Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival. Clinical cancer research 2009, 15: 4538    
Harrison CJ, Hills RK, Moorman AV, Grimwade DJ, Hann I, Webb DK, Wheatley K, de Graaf SS, van den Berg E, Burnett AK, Gibson BE Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12. Journal of clinical oncology 2010, 28: 2674    
Harigae H Iron metabolism and related diseases: an overview. International journal of hematology 2018, 107: 5    
Hariharan N, Brunson A, Mahajan A, Keegan THM, Wun T Bleeding in patients with sickle cell disease: a population-based study. Blood advances 2020, 10; 4: 793    
Hariz A, Priyanka T, Bhattacharya PT Megaloblastic Anemia. In: StatPearls [Internet]. Treasure Island (FL) StatPearls Publishing; 2020    
Hasle H, Arico M, Basso G, Biondi A, Cantu Rajnoldi, Creutzig U, Fenu S, Fonatsch C, Haas O, Harbott J, Kardos G, Kerndrup G, Mann G, Niemeyer C, Ptoszkova H, Ritter J, Slater R, Stary J, Stollmann-Gibbels B, Testi A, van Wering E, Zimmermann M Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). Leukemia 1999, 13: 376    
Hasle H Pattern of malignant disorders in individuals with Down's syndrome. The Lancet. Oncology 2001, 2: 429    
Hasle H, Niemeyer C, Chessells J, Baumann I, Bennett J, Kerndrup G, Head D A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003, 17: 277    
Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, Head DR A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003, 17: 277    
Hasle H, Baumann I, Bergstrasser E, Fenu S, Fischer A, Kardos G, Kerndrup G, Locatelli F, Rogge T, Schultz KR, Stary J, Trebo M, van den Heuvel-Eibrink MM, Harbott J, Nollke P, Niemeyer CM, European Working Group on childhood MDS The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML). Leukemia 2004, 18: 2008    
Hasle H, Alonzo TA, Auvrignon A, Behar C, Chang M, Creutzig U, Fischer A, Forestier E, Fynn A, Haas OA, Harbott J, Harrison CJ, Heerema NA, van den Heuvel-Eibrink MM, Kaspers GJ, Locatelli F, Noellke P, Polychronopoulou S, Ravindranath Y, Razzouk B, Reinhardt D, Savva NN, Stark B, Suciu S, Tsukimoto I, Webb DK, Wojcik D, Woods WG, Zimmermann M, Niemeyer CM, Raimondi SC Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007, 109: 4641    
Hasselblatt M, Mühlisch J, Wrede B, Kallinger B, Jeibmann A, Peters O, Kutluk T, Wolff JE, Paulus W, Frühwald MC Aberrant MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation in choroid plexus tumors. J Neurooncol 2009, 91: 151    
Hasle H, Niemeyer CM Advances in the prognostication and management of advanced MDS in children. Br J Haematol 2011, 154: 185    
Hasselblatt M, Gesk S, Oyen F, Rossi S, Viscardi E, Giangaspero F, Giannini C, Judkins AR, Frühwald MC, Obser T, Schneppenheim R, Siebert R, Paulus W Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. The American journal of surgical pathology 2011, 35: 933    
Hashmi M, Wasay M Caring for cerebral venous sinus thrombosis in children. Journal of emergencies, trauma, and shock 2011, 4: 389    
Hasenclever D, Kurch L, Mauz-Körholz C, Elsner A, Georgi T, Wallace H, Landman-Parker J, Moryl-Bujakowska A, Cepelová M, Karlén J, Álvarez Fernández-Teijeiro A, Attarbaschi A, Fosså A, Pears J, Hraskova A, Bergsträsser E, Beishuizen A, Uyttebroeck A, Schomerus E, Sabri O, Körholz D, Kluge R qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. European journal of nuclear medicine and molecular imaging 2014, 41: 1301    
Hasselblatt M, Nagel I, Oyen F, Bartelheim K, Russell RB, Schüller U, Junckerstorff R, Rosenblum M, Alassiri AH, Rossi S, Schmid I, Gottardo NG, Toledano H, Viscardi E, Balbin M, Witkowski L, Lu Q, Betts MJ, Foulkes WD, Siebert R, Frühwald MC, Schneppenheim R SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis. Acta neuropathologica 2014, 128: 453    
Hassler A, Bochennek K, Gilfert J, Perner C, Schöning S, Creutzig U, Reinhardt D, Lehrnbecher T Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004. Pediatr Blood Cancer 2016, [Epub ahead of print]    
Hasselblatt M, Thomas C, Hovestadt V, Schrimpf D, Johann P, Bens S, Oyen F, Peetz-Dienhart S, Crede Y, Wefers A, Vogel H, Riemenschneider MJ, Antonelli M, Giangaspero F, Bernardo MC, Giannini C, Ud Din N, Perry A, Keyvani K, van Landeghem F, Sumerauer D, Hauser P, Capper D, Korshunov A, Jones DT, Pfister SM, Schneppenheim R, Siebert R, Frühwald MC, Kool M Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis. Acta neuropathologica 2016, 132: 149    
Hasle H Myelodysplastic and myeloproliferative disorders of childhood. Hematology. American Society of Hematology. Education Program 2016 Dec 2; 2016, 598    
Hasselblatt M, Johann PD, Kool M, Frühwald MC Reduced histone H3 K27 trimethylation is encountered in about 50% of atypical teratoid/rhabdoid tumors (AT/RT) but is not associated with molecular subgroup status and outcome. Acta neuropathologica 2017, 134: 817    
Hastka J, Metzgeroth G, Gattermann N Eisenmangel und Eisenmangelanämie. Onkopedia Leitlinien Stand 2018, aufgerufen am 10.12.2020    
Hasselblatt M, Thomas C, Nemes K, Monoranu CM, Riemenschneider MJ, Koch A, Sumerauer D, Hauser P, Paulus W, Johann PD, Kool M, Frühwald MC Tyrosinase immunohistochemistry can be employed for the diagnosis of atypical teratoid/rhabdoid tumours of the tyrosinase subgroup (ATRT-TYR). Neuropathology and applied neurobiology 2020, 46: 186    
Hasselblatt M, Thomas C, Nemes K, Monoranu CM, Riemenschneider MJ, Koch A, Sumerauer D, Hauser P, Paulus W, Johann PD, Kool M, Frühwald MC Tyrosinase immunohistochemistry can be employed for the diagnosis of atypical teratoid/rhabdoid tumours of the tyrosinase subgroup (ATRT-TYR). Neuropathology and applied neurobiology 2020, 46: 186    
Haupt R, Fears T, Heise A, Gadner H, Loiacono G, De Terlizzi M, Tucker M Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. Int J Cancer 1997, 71: 9    
Haupt R, Spinetta JJ, Ban I, Barr RD, Beck JD, Byrne J, Calaminus G, Coenen E, Chesler M, D'Angio GJ, Eiser C, Feldges A, Gibson F, Lackner H, Masera G, Massimo L, Magyarosy E, Otten J, Reaman G, Valsecchi MG, Veerman AJ, Penn A, Thorvildsen A, van den Bos C, Jankovic M, International Berlin-Frankfurt-Münster Study Group Early and Late Toxicity Educational Committee (I-BFM-SG ELTEC) Long term survivors of childhood cancer: cure and care. The Erice statement. European journal of cancer (Oxford, England : 1990) 2007, 43: 1778    
Hauffa BP, Scimic-Schleicher G Pubertas tarda und Hypogonadismus. Leitlinie der Deutschen Gesellschaft für Kinderheilkunde und Jugendmedizin AWMF online 2011    
Hauer J, Fischer U, Borkhardt A Toward prevention of childhood ALL by early-life immune training. Blood 2021, 138: 1412    
Haveman LM, Ranft A, Berg HVD, Klco-Brosius S, Ladenstein R, Paulussen M, Jürgens H, Dirksen U, Merks JHM Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review. Cancers 2020, 12    
Haveman LM, van Ewijk R, van Dalen EC, Breunis WB, Kremer LC, van den Berg H, Dirksen U, Merks JH High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma. The Cochrane database of systematic reviews 2021 Sep 2; 9:CD011405    
Haveman LM, van Ewijk R, van Dalen EC, Breunis WB, Kremer LC, van den Berg H, Dirksen U, Merks JH High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma. The Cochrane database of systematic reviews 2021, 9:CD011405    
Hawkins DS, Schuetze SM, Butrynski JE, Rajendran JG, Vernon CB, Conrad EU 3rd, Eary JF [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005, 23: 8828    
Hay KA, Hanafi LA, Li D, Gust J, Liles WC, Wurfel MM, López JA, Chen J, Chung D, Harju-Baker S, Cherian S, Chen X, Riddell SR, Maloney DG, Turtle CJ Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood 2017, 130: 2295    
Hayden J, Murray MJ, Bartels U, Ajithkumar T, Muthusamy B, Penn A, Calaminus G, Nicholson J Symptom interval and treatment burden for patients with malignant central nervous system germ cell tumours. Archives of disease in childhood 2020, 105: 247    
Hebart H, Lang P, Woessmann W Nivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case Report. Annals of internal medicine 2016, 165: 607    
Hechler T, Chalkiadis GA, Hasan C, Kosfelder J, Meyerhoff U, Vocks S, Zernikow B Sex differences in pain intensity in adolescents suffering from cancer: differences in pain memories? The journal of pain 2009, 10: 586    
Hecker-Nolting S Osteosarkome. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie 2021    
Hecker-Nolting S, Langer T, Blattmann C, Kager L, Bielack SS Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients. Cancer management and research 2021, 13: 8989    
Hecker-Nolting S, Baumhoer D, Blattmann C, Kager L, Kühne T, Kevric M, Lang S, Mettmann V, Sorg B, Werner M, Bielack SS Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS). Journal of cancer research and clinical oncology 2023, 149: 1961    
Hecker-Nolting S, Kager L, Kühne T, Baumhoer D, Blattmann C, Friedel G, von Kalle T, Kevric M, Mayer-Steinacker R, Schwarz R, Sorg B, Wirth T, Bielack SS Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis. Journal of adolescent and young adult oncology 2023, 12: 76    
Hedborg F, Franklin G, Norrman J, Grimelius L, Wassberg E, Hero B, Schilling F, Berthold F, Harms D, Sandstedt B Evidence of chromaffin oxygen sensing in neuroblastoma. Med Pediatr Oncol 2001, 36: 149    
Hedborg F, Ulleras E, Grimelius L, Wassberg E, Maxwell P, Hero B, Berthold F, Schilling F, Harms D, Sandstedt B, Franklin G Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma. FASEB J 2003, 17: 598    
Heerema N, Harbott J, Galimberti S, Camitta B, Gaynon P, Janka-Schaub G, Kamps W, Basso G, Pui C, Schrappe M, Auclerc M, Carroll A, Conter V, Harrison C, Pullen J, Raimondi S, Richards S, Riehm H, Sather H, Shuster J, Silverman L, Valsecchi M, Arico M Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Leukemia 2004, 18: 693    
Heesen P, Ranft A, Bhadri V, Brichard B, Collaud S, Cyprova S, Eich H, Ek T, Gelderblom H, Hardes J, Haveman L, Jabar S, Hartmann W, Andreou D, Hauser P, Kersting J, Jürgens H, Kanerva J, Kühne T, Raciborska A, Rascon J, Streitbürger A, Timmermann B, Uhlenbruch Y, Dirksen U Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial. European journal of cancer (Oxford, England : 1990) 2023, 192: 113260    
Heger S, Paetow U S1-Leitlinie – Pubertas praecox: Leitlinie der Deutschen Gesellschaft für Kinderendokrinologie und -diabetologie (DGKED) e. V. AWMF online 2019    
Heinsohn S, Scholz R, Weber B, Wittenstein B, Werner M, Delling G, Kempf-Bielack B, Setlak P, Bielack S, Kabisch H SV40 sequences in human osteosarcoma of German origin. Anticancer Res 2000, 20: 4539    
Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, Griesshammer A, Marquardt T, Janka-Schaub G, Kron M, Kohne E Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 2003, 102: 4576    
Heimpel H Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis. Annals of hematology 2004, 83: 613    
Heimpel H, Iolascon, A Congenical dyserythropoietic anemias. In: Beaument C, Beris, Ph, Beuzard, Y, Brugnara, C editors, ESH Handbook on Disorders of Erythropoiesis, Erythrocytes and Iron Metabolism 2009, 2nd edition, p178    
Heinemann M, Ranft A, Jürgens H, Langer T, Vieth V, Timmermann B, Weckesser M, Dirksen U, Stegger L Ewing sarcoma during follow-up. Nuklearmedizin. Nuclear medicine 2017, 56: 233    
Heinks K, Boekhoff S, Hoffmann A, Warmuth-Metz M, Eveslage M, Peng J, Calaminus G, Müller HL Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. Endocrine 2018, 59: 364    
Heinemann M, Ranft A, Langer T, Jürgens H, Kreyer J, Vieth V, Schäfers M, Weckesser M, Simon T, Hassenpflug W, Corbacioglu S, Bielack S, Mayer-Steinacker R, Kühne T, van den Berg H, Gelderblom H, Bauer S, Stegger L, Dirksen U Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage? Pediatric blood & cancer 2018, 65:e27011    
Heidelberg University Hospital Protonentherapie und Schwerionentherapie – hochpräzise Behandlung gegen Krebs. Webseite des Heidelberg University Hospital aufgerufen am 23.05.2019    
Heinks K, De Schutter-Nüsse C, Boekhoff S, Bogusz A, Zhu J, Peng J, Müller HL Periostin concentrations in childhood-onset craniopharyngioma patients. Journal of endocrinological investigation 2019, 42: 815    
Heinemann M, Hoffmann C, Hardes J, Guder W, Streitbürger A, Götte M, Welz TL, Jürgens H, Ranft A, Vieth V, Weckesser M, Schäfers M, Stegger L, Dirksen U Pain in survivors of Ewing sarcoma: Prevalence, associated factors and prediction of recurrence. Pediatric blood & cancer 2021, 68:e28801    
Heipertz AE, Pajtler KW, Pfaff E, Schramm K, Blattner-Johnson M, Milde T, Jones BC, Zuliani C, Hutter C, Lohi O, Kattamis A, Dachowska-Kalwak I, Nilsson A, Gerber NU, Langenberg KPS, Goemans B, Zwaan CM, Molenaar JJ, Jäger N, Dirksen U, Witt R, Pfister SM, Jones DTW, Kopp-Schneider A, Witt O, van Tilburg CM Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM. JCO precision oncology 2023, 7:e2300015    
Heinz AT, Ebinger M, Schönstein A, Fuchs J, Timmermann B, Seitz G, Vokuhl C, Münter MW, Pajtler KW, Stegmaier S, von Kalle T, Kratz CP, Rößler J, Ljungman G, Klingebiel T, Koscielniak E, Sparber-Sauer M, Cooperative Weichteilsarkom Studiengruppe (CWS) Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR). Pediatric blood & cancer 2023, 70:e30363    
Heinz AT, Schönstein A, Ebinger M, Fuchs J, Timmermann B, Seitz G, Vokuhl C, Münter M, Pajtler KW, Stegmaier S, von Kalle T, Kratz CP, Ljungman G, Juntti H, Klingebiel T, Koscielniak E, Sparber-Sauer M, Cooperative Weichteilsarkom Studiengruppe Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR. Pediatric blood & cancer 2023,:e30707    
Hellenbrecht A Kinderwunsch und Hormonhaushalt. WIR 2005, 1    
Hempel L, Kremens B, Weirich A, Graf N, Zintl F, Ludwig R High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP 9/GPOH trial and study. Klin Pädiatr 1996, 208: 186    
Hempel G, Reinhardt D, Creutzig U, Boos J Population pharmacokinetics of liposomal daunorubicin in children. Br J Clin Pharmacol 2003, 56: 370    
Hempel L, Sauerbrey A, Zintl F, Weirich A, Lemmer A, Graf N Successful management of a child with clear cell sarcoma of the kidney (CCSK) and multifocal bone metastases at diagnosis. Med Pediatr Oncol 2003, 41: 97    
Hempel G, Müller HJ, Lanvers-Kaminsky C, Würthwein G, Hoppe A, Boos J A population pharmacokinetic model for pegylated-asparaginase in children. British journal of haematology 2010, 148: 119    
Henter JI, Elinder G, Ost A Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Seminars in oncology 1991, 18: 29    
Henze G, Fengler R, Hartmann R Chemotherapy for relapsed childhood acute lymphoblastic leukemia. Haematol Blood Transfus 1994, 36: 374    
Henze G, Hartmann R, Fengler R Salvage therapy of childhood ALL. Haematol Blood Transfus 1995, 223    
Henze G Agthe AG, Neuendank A, Hartmann R, Dörffel W, Brühmüller S, Klumper E, Pieters R, Veerman AJ Tailored therapy for relapsed or refractory childhood acute lymphoblastic leukaemia. Leukemia 1995, 9 : 538    
Henze G Autologe Knochenmarktransplantation versus Chemotherapie bei Kindern mit akuter lymphoblastischer Leukämie in zweiter Remission. Deutsches Ärzteblatt 1996, 93: 935    
Henter J, Arico M, Egeler R, Elinder G, Favara B, Filipovich A, Gadner H, Imashuku S, Janka-Schaub G, Komp D, Ladisch S, Webb D HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 1997, 28: 342    
Henze G Chemotherapy for relapsed childhood acute lymphoblastic leukemia. Int J Pediatr Hematol Oncol 1998, 5: 199    
Henze G, Borgmann A, Stackelberg A, Baumgarten E, Uchanska-Ziegler B, Ziegler A, Wittig B Immunotherapy of acute lymphoblastic leukemia by vaccination with autologoues leukemic cells transfected with a cDNA expression plasmid coding for an allogeneic HLA class I antigen combined with interleukin-2 treatment. J Mol Med 1998, 76: 215    
Hense H, Ahrens S, Paulussen M, Lehnert M, Jürgens H Factors associated with tumor volume and primary metastases in Ewing tumors. Ann Oncol 1999, 10: 1073    
Hense H, Ahrens S, Paulussen M, Lehnert M, Jürgens H Descriptive epidemiology of Ewing's tumor--analysis of German patients from (EI)CESS 1980-1997. Klin Pädiatr 1999, 211: 271    
Henze G Leukämien. In:Gutjahr, P , Krebs bei Kindern und Jugendlichen Deutscher Ärzte-Verlag, Köln, 4 Auflage 1999, 240    
Henze G, Herold R, Creutzig U Kompetenznetz Pädiatrische Onkologie und Hämatologie nach der ersten Förderperiode - zukünftige Pläne. Monatsschrift für Kinderheilkunde 2002, 150    
Henter JI, Samuelsson-Horne A, Aricò M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G, Histocyte Society Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002, 100: 2367    
Henze G Kryokonservierung von Nabelschnurstammzellen bei Neugeborenen zur eventuellen späteren Eigennutzung. Die Mitteilungen von GPOH und KPOH 2003, 1: 7    
Henze G Leukämien, in Gutjahr P: Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 293    
Henze G 20 Jahre Studien zur Behandlung von Kindern mit Rezidiv einer akuten lymphoblastischen Leukämie (ALL-REZ BFM). WIR Informationsschrift der Aktion für krebskranke Kinder e.V. (Bonn) 2004, 3: 13    
Henze G Maligne Non-Hodgkin-Lymphome, in Gutjahr P: Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 328    
Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric blood & cancer 2007, 48: 124    
Hennes E, Zahn S, Lopes LF, Schönberger S, Leuschner I, Göbel U, Calaminus G, Schneider DT Molecular genetic analysis of bilateral ovarian germ cell tumors. Klinische Padiatrie 2012, 224: 359    
Henrichs M-P, Hardes J, Jürgens H Maligne Knochentumoren. in: Solide Tumoren im Kindesalter. Fuchs J (Hrsg.), Schattauer GmbH Stuttgart 2012, 330    
Henze G, v Stackelberg A, Eckert C ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia. Klinische Padiatrie 2013, 225 Suppl 1:S73    
Hennewig U, Kaatsch P, Blettner M, Spix C Local radiation dose and solid second malignant neoplasms after childhood cancer in Germany: a nested case-control study. Radiation and environmental biophysics 2014, 53: 485    
Henry ER, Metaferia B, Li Q, Harper J, Best RB, Glass KE, Cellmer T, Dunkelberger EB, Conrey A, Thein SL, Bunn HF, Eaton WA Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin. Blood 2021, Online ahead of print    
Hero B, Holschneider A, Berthold F Risk and benefits of surgical interventions in localized neuroblastoma--experiences from cooperative studies in Germany. Langenbecks Arch Chir Suppl Kongressbd 1996, 113: 1062    
Hertzberg H, Langer T Probleme der Chemotherapie im Kindesalter. mta 1996, 796    
Hero B, Kremens B, Klingebiel T, Bender-Gotze C, Burdach S, Schrappe M, Berthold F Does megatherapy contribute to survival in metastatic neuroblastoma? Klin Pädiatr 1997, 209: 196    
Hertzberg H, Huk W, Überall M, Langer T, Meier W, Dopfer R, Skalej M, Lackner H, Bode U, Janssen G, Zintl F, Beck J CNS late effects after ALL therapy in childhood. Part I Med Pediatr Oncol 1997, 28: 387    
Herold R, Creutzig U, Henze G Kompetenznetz Pädiatrische Onkologie und Hämatologie. humboldt spektrum 1999, 4: 4    
Herold R, Creutzig U, Henze G Kompetenznetz Pädiatrische Onkologie und Hämatologie. InFoOnkologie 1999, 5: 292    
Hero B, Berthold F Neuroblastoma. Leitlinien Kinderheilkunde und Jugendmedizin, D Reinhardt (Hrsg ), Urban & Fischer 2000, 1    
Hero B, Simon T, Horz S, Berthold F Metastatic neuroblastoma in infancy. Med Pediatr Oncol 2000, 35: 683    
Hero B, Hunneman D, Gahr M, Berthold F Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma. Med Pediatr Oncol 2001, 36: 220    
Herold R, Henze G, Creutzig U Kompetenznetz Pädiatrische Onkologie und Hämatologie. Lebendige Wissenschaft - Medizin 2001,alpha Verlag Lampertheim    
Herold Ralf, Creutzig Ursula, Pommerening Klaus Use of an internet based knowledge Server for the Medical Research Network Pediatric Oncology and Hematology. Onkologie 2001, 24: 169    
Hertzberg H, Kremens B, Velten I, Beck JD, Greil J Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation. Bone marrow transplantation 2001, 27: 653    
Hero B, Berthold F Neuroblastom. Monatschr Kinderheilkd 2002, 150: 775    
Hero B, Graf N, Simon T, Weirich A, Troger J, Berthold F Neuroblastoma preoperatively treated as nephroblastoma. Klin Pädiatr 2002, 214: 157    
Herold R, Berthold F Erfahrungen und praktische Regeln beim Kodieren von Diagnosen und Prozeduren in der Pädiatrischen Onkologie und Hämatologie [Abstract]. Monatsschrift für Kinderheilkunde 2002, 150    
Herold R, Grieámeier B, Tallen G, Henze G Nicht mehr krank, doch gesund noch lange nicht - Zur Situation von krebskranken Kindern und Jugendlichen. Forum Public Health 2002, 10: 13    
Herold R, Stibenz D, Hartmann R, Henze G, Bührer C Soluble l-selectin (sCD62L) in relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 2002, 119: 677    
Herold R, Tallen G, Creutzig U Neuer Informationsserver im Internet für Betroffene, Fachleute und Laien der Pädiatrischen Onkologie und Hämatologie. Monatsschrift für Kinderheilkunde 2002, 150    
Herold R, Zimmermann M Konzepte und Perspektiven der elektronischen Unterstützung für die Medizinische Dokumentation in der Pädiatrischen Onkologie und Hämatologie [Abstract]. Monatsschrift für Kinderheilkunde 2002, 150    
Herold R, Von Stackelberg A, Hartmann R, Eisenreich B, Henze G Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group (ALL-REZ BFM) experience. J Clin Oncol 2004, 22: 569    
Hero B, Berthold F Neuroblastoma. In: D. Reinhard (Hrsg.), Leitlinien Kinderheilkunde und Jugendmedizin Urban & Fischer, 2005, L5 1    
Hering A, Michel S, Ernst G, Claussen U, Kloetzer Ch, Parlowsky T, Bucsky P, Loncarevic IF Characteristic chromosomal imbalances in pediatric pheochromocytoma. Genes Chromosomes and Cancer (accepted paper)    
Hero B, Berthold F Neuroblastome. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädiatrische Onkologie und Hämatologie 2005    
Herold R, Reiche R, Creutzig U, Henze G [Assessment of staffing and infrastructures of paediatric oncology and haematology centres in Germany]. Klinische Padiatrie 2007, 219: 380    
Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. Journal of clinical oncology 2008, 26: 1504    
Hernáiz Driever P, von Hornstein S, Pietsch T, Kortmann R, Warmuth-Metz M, Emser A, Gnekow AK Natural history and management of low-grade glioma in NF-1 children. J Neurooncol 2010,    
Hero B, Papenheim H, Schuster U Neuroblastom – Informationen für Eltern. Fördergesellschaft Kinderkrebs-Neuroblastom-Forschung e.V., Baden 2011    
Hero B, Clement N, Oera I, Pierron G, Lapouble E, Theissen J, Pasqualini C, Valteau-Couanet D, Plantaz D, Michon J, Delattre O, Tardieu M, Schleiermacher G Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus Syndrome. Journal of pediatric hematology/oncology 2018, 40: 93    
Hettmer S, Linardic CM, Kelsey A, Rudzinski ER, Vokuhl C, Selfe J, Ruhen O, Shern JF, Khan J, Kovach AR, Lupo PJ, Gatz SA, Schäfer BW, Volchenboum S, Minard-Colin V, Koscielniak E, Hawkins DS, Bisogno G, Sparber-Sauer M, Venkatramani R, Merks JHM, Shipley J Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. European journal of cancer (Oxford, England : 1990) 2022, 172: 367    
van den Heuvel-Eibrink MM, van Tinteren H, Rehorst H, Coulombe A, Patte C, de Camargo B, de Kraker J, Leuschner I, Lugtenberg R, Pritchard-Jones K, Sandstedt B, Spreafico F, Graf N, Vujanic GM Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study group. Pediatr Blood Cancer 2010 [Epub ahead of print]    
Heukamp LC, Thor T, Schramm A, De Preter K, Kumps C, De Wilde B, Odersky A, Peifer M, Lindner S, Spruessel A, Pattyn F, Mestdagh P, Menten B, Kuhfittig-Kulle S, Künkele A, König K, Meder L, Chatterjee S, Ullrich RT, Schulte S, Vandesompele J, Speleman F, Büttner R, Eggert A, Schulte JH Targeted expression of mutated ALK induces neuroblastoma in transgenic mice. Sci Transl Med 2012, 4: 141ra91    
van den Heuvel-Eibrink MM, van Tinteren H, Bergeron C, Coulomb-L'Hermine A, de Camargo B, Leuschner I, Sandstedt B, Acha T, Godzinski J, Oldenburger F, Gooskens SL, de Kraker J, Vujanic GM, Pritchard-Jones K, Graf N Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). European journal of cancer (Oxford, England : 1990) 2015,Epub ahead of print    
van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, van Tinteren H, Furtwängler R, Verschuur AC, Vujanic GM, Leuschner I, Brok J, Rübe C, Smets AM, Janssens GO, Godzinski J, Ramí­rez-Villar GL, de Camargo B, Segers H, Collini P, Gessler M, Bergeron C, Spreafico F, Graf N, International Society of Paediatric Oncology -Renal Tumour Study Group (SIOP-RTSG) Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nature reviews. Urology 2017, 14: 743    
van den Heuvel-Eibrink MM, Fernandez CV, Graf N, Geller JI Progress by international collaboration for pediatric renal tumors by HARMONIzation and COllaboration: The HARMONICA initiative. Pediatric blood & cancer 2023, 70 Suppl 2:e30082    
Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood 2013, 122: 3879    
Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA Five hematologic tests and treatments to question. Blood 2014, 124: 3524    
Hiddemann W, Ritter J, Wormann B, Budde M, Creutzig U, Schellong G, Buchner T, Riehm H DNA aneuploidy in children with acute leukemia. Klin Pädiatr 1985, 197: 215    
Hiddemann W, Harbott J, Ludwig W, Ritter J, Nehmer A, Reiter A, Kolkmeyer A, Laing T, Riehm H DNA aneuploidy in childhood acute lymphoblastic leukemia. Recent Results Cancer Res 1993, 131: 113    
Hijiya N, Millot F, Suttorp M Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions. Pediatric clinics of North America 2015, 62: 107    
Hijiya N, Schultz KR, Metzler M, Millot F, Suttorp M Pediatric chronic myeloid leukemia is a unique disease that requires a different approach. Blood 2016, 127: 392    
Hillmann A, Ozaki T, Rübe C, Hoffmann C, Schuck A, Blasius S, Haas A, Jürgens H, Winkelmann W Surgical complications after preoperative irradiation of Ewing's sarcoma. J Cancer Res Clin Oncol 1997, 123: 57    
Hilgendorf I, Freund M, Jilg W, Einsele H, Gea-Banacloche J, Greinix H, Halter J, Lawitschka A, Wolff D, Meisel R Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. Vaccine 2011 Apr 5; 29: 2825    
Hill RM, Plasschaert SLA, Timmermann B, Dufour C, Aquilina K, Avula S, Donovan L, Lequin M, Pietsch T, Thomale U, Tippelt S, Wesseling P, Rutkowski S, Clifford SC, Pfister SM, Bailey S, Fleischhack G Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment. Cancers 2021, 14    
Hing S, Lu Y, Summersgill B, King-Underwood L, Nicholson J, Grundy P, Grundy R, Gessler M, Shipley J, Pritchard-Jones K Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol 2001, 158: 393    
Hippert F, Desing L, Diez S, Witowski A, Bernbeck B, Abele M, Seitz C, Erdmann F, Brecht I, Schneider DT Rare Tumors in Children and Adolescents - the STEP Working Group's Evolution to a Prospective Registry. Klinische Padiatrie 2022, 234: 146    
Hirsch JF, Sainte Rose C, Pierre-Kahn A, Pfister A, Hoppe-Hirsch E Benign astrocytic and oligodendrocytic tumors of the cerebral hemispheres in children. J Neurosurg 1989, 70: 568    
Hirst C, Owusu-Ofori S Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. The Cochrane database of systematic reviews 2014, 11:CD003427    
Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 2003 Jun 1; 101: 4301    
Holsten T, Tsiakas K, Kordes U, Bison B, Pietsch T, Rutkowski S, Santer R, Schüller U Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2018, 34: 581    
Hochhaus A, Baerlocher GM, Brümmendorf TH, le Coutre P, Metzler M, Pelzer A, Saußele S, Suttorp M, Wolf D Chronische Myeloische Leukämie (CML). Onkopedia Leitlinien – Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen; Hrsg. DGHO Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V 2018    
Hoene V, Fischer M, Ivanova A, Wallach T, Berthold F, Dame C GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes. British journal of cancer 2009, 101: 1481    
Hoell JI, Ginzel S, Kuhlen M, Kloetgen A, Gombert M, Fischer U, Hein D, Demir S, Stanulla M, Schrappe M, Zur Stadt U, Bader P, Babor F, Schuster F, Strahm B, Alten J, Moericke A, Escherich G, von Stackelberg A, Thiele R, McHardy AC, Peters C, Bornhauser B, Bourquin JP, Krause S, Enczmann J, Meyer LH, Eckert C, Borkhardt A, Meisel R Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets. Blood advances 2019, 3: 3143    
Hötker AM, Mazaheri Y, Lollert A, Schenk JP, Zheng J, Capanu M, Akin O, Graf N, Staatz G Diffusion-weighted MRI and histogram analysis: assessment of response to neoadjuvant chemotherapy in nephroblastoma. Abdominal radiology (New York) 2021, 46: 3317    
Hoffmann C, Jabar S, Ahrens S, Rödl R, Rübe C, Winkelmann W, Dunst J, Jürgens H Prognosis in Ewing sarcoma patients with initial pathological fractures of the primary tumor site. Klin Pädiatr 1995, 207: 151    
Hoffmann C, Ahrens S, Dunst J, Hillmann A, Winkelmann W, Craft A, Göbel U, Rübe C, Voute P, Harms D, Jürgens H Pelvic Ewing sarcoma. A retrospective analysis of 241 cases. Cancer 1999, 85: 869    
Hoffmann C, Gosheger G, Gebert C, Jürgens H, Winkelmann, N Functional results and quality of life after treatment of pelvic sarcomas involving the acetabulum. J Bone Joint Surg Am 88A; 3/2006, 575    
von Hoff K, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD, Kuehl J, Rutkowski S Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. European journal of cancer (Oxford, England : 1990) 2009, 45: 1209    
von Hoff K, Hartmann W, von Bueren AO, Gerber NU, Grotzer MA, Pietsch T, Rutkowski S Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. Pediatric blood & cancer 2010, 54: 369    
Hof J, Krentz S, van Schewick C, Körner G, Shalapour S, Rhein P, Karawajew L, Ludwig WD, Seeger K, Henze G, von Stackelberg A, Hagemeier C, Eckert C, Kirschner-Schwabe R Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia. J Clin Oncol 2011, [Epub ahead of print]    
von Hoff K, Hinkes B, Dannenmann-Stern E, von Bueren AO, Warmuth-Metz M, Soerensen N, Emser A, Zwiener I, Schlegel PG, Kuehl J, Frühwald MC, Kortmann RD, Pietsch T, Rutkowski S Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatric blood & cancer 2011, 1; 57: 978    
Hofmann M, Schlegel PG, Hippert F, Schmidt P, von-Schweinitz D, Leuschner I, Göbel U, Calaminus G, Schneider DT, MAKEI study group Testicular sex cord stromal tumors: Analysis of patients from the MAKEI study. Pediatric blood & cancer 2013, 60: 1651    
Hoffmann A, Gebhardt U, Sterkenburg A, Warmuth-Metz M, Müller HL Diencephalic syndrome in childhood craniopharyngioma -Results of German multicentre studies on 485 long-term survivors of childhood craniopharyngioma. The Journal of clinical endocrinology and metabolism 2014,jc20141680    
Hoffmann A, Warmth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, Calaminus G, Müller HL Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Klinische Padiatrie 2014, 226: 161    
Hoffmann A, Brentrup A, Mueller HL First report on spinal metastasis in childhood-onset craniopharyngioma. Journal of neuro-oncology 2016, 129: 193    
Hoffmann A, Warmuth-Metz M, Lohle K, Reichel J, Daubenbuechel AM, Sterkenburg AS, Mueller HL Fusiform dilatation of the internal carotid artery in childhood-onset craniopharyngioma: multicenter study on incidence and long-term outcome. Pituitary 2016, 19: 422    
vom Hoff, Katja Therapieoptimierungsstudie SIOP-Ependymom II. WIR - Zeitschrift der Deutschen Kinderkrebsstiftung und der Deutschen Leukämie-Forschungshilfe e.V 2/17    
Hoffmann A, Azyurt J, Lohle K, Reichel J, Thiel CM, Mueller HL First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma. Endocrine 2017, 56: 175    
Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, Carret AS, Escorza NY, Hassall T, Ziegler DS, Gottardo N, Dholaria H, Doughman R, Benesch M, Drissi R, Nazarian J, Jabado N, Boddaert N, Varlet P, Giraud G, Castel D, Puget S, Jones C, Hulleman E, Modena P, Giagnacovo M, Antonelli M, Pietsch T, Gielen GH, Jones DTW, Sturm D, Pfister SM, Gerber NU, Grotzer MA, Pfaff E, von Bueren AO, Hargrave D, Solanki GA, Jadrijevic Cvrlje F, Kaspers GJL, Vandertop WP, Grill J, Bailey S, Biassoni V, Massimino M, Calmon R, Sanchez E, Bison B, Warmuth-Metz M, Leach J, Jones B, van Vuurden DG, Kramm CM, Fouladi M Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. Journal of clinical oncology 2018 Jul 1; 36: 1963    
Hoffman LM, Richardson EA, Ho B, Margol A, Reddy A, Lafay-Cousin L, Chi S, Slavc I, Judkins A, Hasselblatt M, Bourdeaut F, Frühwald MC, Vibhakar R, Bouffet E, Huang A Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors. Neuro-oncology 2020, 22: 944    
von Hoff K, Haberler C, Schmitt-Hoffner F, Schepke E, de Rojas T, Jacobs S, Zapotocky M, Sumerauer D, Perek-Polnik M, Dufour C, van Vuurden D, Slavc I, Gojo J, Pickles JC, Gerber NU, Massimino M, Gil-da-Costa MJ, Garami M, Kumirova E, Sehested A, Scheie D, Cruz O, Moreno L, Cho J, Zeller B, Bovenschen N, Grotzer M, Alderete D, Snuderl M, Zheludkova O, Golanov A, Okonechnikov K, Mynarek M, Juhnke BO, Rutkowski S, Schüller U, Pizer B, von Zezschwitz B, Kwiecien R, Wechsung M, Konietschke F, Hwang EI, Sturm D, Pfister SM, von Deimling A, Rushing EJ, Ryzhova M, Hauser P, Łastowska M, Wesseling P, Giangaspero F, Hawkins C, Figarella-Branger D, Eberhart C, Burger P, Gessi M, Korshunov A, Jacques TS, Capper D, Pietsch T, Kool M Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study. Neuro-oncology 2021, 23: 1597    
Hohlfeld Th Hämostasestörungen durch Analgetika, Antiphlogistika und Antirheumatika. Hämostasiologie 2001, 01, 22    
Hohmann C, Borgmann A, Keil T Re: Induced abortions in Danish cancer survivors: a population-based cohort study. J Natl Cancer Inst 2011, 20; 103: 698    
Hohmann C, Borgmann-Staudt A, Rendtorff R, Reinmuth S, Holzhausen S, Willich SN, Henze G, Goldbeck L, Keil T Patient counselling on the risk of infertility and its impact on childhood cancer survivors: results from a national survey. Journal of psychosocial oncology 2011, 29: 274    
Holter W, Ressmann G, Grois N, Lehner M, Parolini O, Gadner H Normal monocyte-derived dendritic cell function in patients with Langerhans-cell-histiocytosis. Medical and pediatric oncology 2002, 39: 181    
Holleman A, Den Boer M, Kazemier K, Janka-Schaub G, Pieters R Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood 2003, 102: 4541    
Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. The New England journal of medicine 2004, 351: 533    
Holleman A, den Boer ML, Kazemier KM, Beverloo HB, von Bergh AR, Janka-Schaub GE, Pieters R Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood 2005, 106: 1817    
Hollink IH, Zwaan CM, Zimmermann M, Arentsen-Peters TC, Pieters R, Cloos J, Kaspers GJ, de Graaf SS, Harbott J, Creutzig U, Reinhardt D, van den Heuvel-Eibrink MM, Thiede C Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia 2009, 23: 262    
Holzhauer S, Goldenberg NA, Junker R, Heller C, Stoll M, Manner D, Mesters R, Krümpel A, Stach M, Nowak-Göttl U Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study. Blood 2012, 120: 1510    
Hol JA, van den Heuvel-Eibrink MM, Graf N, Pritchard-Jones K, Brok J, van Tinteren H, Howell L, Verschuur A, Bergeron C, Kager L, Catania S, Spreafico F, Mavinkurve-Groothuis AMC Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group. Pediatric blood & cancer 2018, 65    
Holsten T, Tsiakas K, Kordes U, Bison B, Pietsch T, Rutkowski S, Santer R, Schüller U Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a. ChNS 2018, 34: 581    
Holzapfel J, Kandels D, Schmidt R, Pietsch T, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Albert MH, Hernáiz Driever P, Witt O, Gnekow AK Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohort. International journal of cancer 2020 Jun 15; 146: 3385    
Holdhof D, Johann PD, Spohn M, Bockmayr M, Safaei S, Joshi P, Masliah-Planchon J, Ho B, Andrianteranagna M, Bourdeaut F, Huang A, Kool M, Upadhyaya SA, Bendel AE, Indenbirken D, Foulkes WD, Bush JW, Creytens D, Kordes U, Frühwald MC, Hasselblatt M, Schüller U Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases. Acta neuropathologica 2021, 141: 291    
Hol JA, Jewell R, Chowdhury T, Duncan C, Nakata K, Oue T, Gauthier-Villars M, Littooij AS, Kaneko Y, Graf N, Bourdeaut F, van den Heuvel-Eibrink MM, Pritchard-Jones K, Maher ER, Kratz CP, Jongmans MCJ Wilms tumour surveillance in at-risk children: Literature review and recommendations from the SIOP-Europe Host Genome Working Group and SIOP Renal Tumour Study Group. European journal of cancer (Oxford, England : 1990) 2021, 153: 51    
Hongo T, Yajima S, Sakurai M, Horikoshi Y, Hanada R In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood 1997, 89: 2959−2965    
Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nature genetics 1999, 23: 433    
von Hornstein S, Kortmann RD, Pietsch T, Emser A, Warmuth-Metz M, Soerensen N, Straeter R, Graf N, Thieme B, Gnekow AK Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial. Pediatric blood & cancer 2011 Jul 1; 56: 1046    
Zur, Hoser G, Reiter A, Welte K, Sykora K Application of long PCR to detect t(8;14)(q24;q32) translocations in childhood Burkitt's lymphoma and B-ALL. Ann Oncol 1997, 8 Suppl 1: 31-5: 31    
Hotfilder M, Lanvers C, Jürgens H, Boos J, Vormoor J c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571). Cancer Chemother Pharmacol 2002, 50: 167    
Hotfilder M, Sondermann P, Senss A, van Valen F, Jürgens H, Vormoor J PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death. British journal of cancer 2005, 92: 705    
Houston SK, Murray TG, Wolfe SQ, Fernandes CE Current update on retinoblastoma. International ophthalmology clinics 2011, 51: 77    
Hovsepyan S, Hakobyan L, Mkhitaryan A, Terenziani M, Ferrari A, Sironi G, Schneider DT, Tamamyan G Treating rare tumors with the assistance of the expert virtual consultation system: two cases of juvenile granulosa cell tumors. Tumori 2021, 107:NP141-NP143    
Howe GR, Burch JD, Chiarelli AM, Risch HA, Choi BC An exploratory case-control study of brain tumors in children. Cancer Res 1989, 49: 4349    
Howell SJ, Shalet SM Effect of cancer therapy on pituitary-testicular axis. International journal of andrology 2002, 25: 269    
Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, Rodgers GP, Powell JD, Tisdale JF Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA 2014, 312: 48    
Hsu JL, Glaser SL Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 2000, 34: 27    
Hua C, Bass JK, Khan R, Kun LE, Merchant TE Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. International journal of radiation oncology, biology, physics 2008 Nov 1; 72: 892    
Hua C, Bass JK, Khan R, Kun LE, Merchant TE Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. International journal of radiation oncology, biology, physics 2008 Nov 1; 72: 892    
Hubner S, Cazzaniga G, Flohr T, van der, Konrad M, Potschger U, Basso G, Schrappe M, van Dongen J, Bartram C, Biondi A, Panzer-Grumayer E High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias. Leukemia 2004, 18: 84    
Hubeek I, Peters GJ, Broekhuizen AJ, Talianidis I, Sigmond J, Gibson BE, Creutzig U, Giaccone G, Kaspers GJ Immunocytochemical detection of deoxycytidine kinase in haematological malignancies and solid tumours. Journal of clinical pathology 2005, 58: 695    
Hubertus J, Boxberger N, Redlich A, von Schweinitz D, Vorwerk P Surgical aspects in the treatment of adrenocortical carcinomas in children: data of the GPOH-MET 97 trial. Klinische Padiatrie 2012, 224: 143    
Hudson MM, Poquette CA, Lee J, Greenwald CA, Shah A, Luo X, Thompson EI, Wilimas JA, Kun LE, Crist WM Increased mortality after successful treatment for Hodgkin's disease. J Clin Oncol 1998, 16: 3592    
Hülsenbeck I, Frank M, Biewald E, Kanber D, Lohmann DR, Ketteler P Introduction of a Variant Classification System for Analysis of Genotype-Phenotype Relationships in Heritable Retinoblastoma. Cancers 2021 Mar 31; 13    
Hughes M, Marsden HB, Palmer MK Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 1974, 34: 1706    
Hug K, Grize L, Seidler A, Kaatsch P, Schüz J Parental occupational exposure to extremely low frequency magnetic fields and childhood cancer: a German case-control study. American journal of epidemiology 2010, 171: 27    
Humpl T Neuroblastome, in: Gutjahr P (Hrsg.): Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 347    
Hunold A, Weddeling N, Paulussen M, Ranft A, Liebscher C, Jürgens H Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors. Pediatric blood & cancer 2006, 47: 795    
Hundsdoerfer P, Dietrich I, Schmelz K, Eckert C, Henze G XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL. Pediatric blood & cancer 2010, 55: 260    
Hunger SP, Tran TH, Saha V, Devidas M, Valsecchi MG, Gastier-Foster JM, Cazzaniga G, Reshmi SC, Borowitz MJ, Moorman AV, Heerema NA, Carroll AJ, Martin-Regueira P, Loh ML, Raetz EA, Schultz KR, Slayton WB, Cario G, Schrappe M, Silverman LB, Biondi A Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial. The Lancet. Haematology 2023, 10:e510-e520    
Hupp M, Falkenstein F, Bison B, Mirow C, Krauß J, Gnekow A, Solymosi L, Warmuth-Metz M Infarction following chiasmatic low grade glioma resection. Child's nervous system 2011,Epub ahead of print    
Häberle H Stationäre familienorientierte Nachsorge, in Schwarz R, Zettl S: Praxis der psychosozialen Onkologie. Verlag für Medizin Fischer 1993    
Häberle H, Schwarz R, Mathes L Familienorientierte Betreuung bei krebskranken Kindern und Jugendlichen. Prax Kinderpsych 1997, 46: 406    
Häberle B, Hero B, Berthold F, von Schweinitz D Characteristics and outcome of thoracic neuroblastoma. Eur J Pediatr Surg 2002, 12: 145    
250 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.